(Q43819597)

English

The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program.

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

fluticasone propionate

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

van den Boom G

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Rutten-van Mölken MP

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Molema J

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Tirimanna PR

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

van Schayck CP

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

164

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

2057-2066

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11739135%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Efficacy of inhaled corticosteroids in asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

New therapies for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

A measure of quality of life for clinical trials in chronic lung disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Economic analysis of respiratory rehabilitation.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

The role of "fear of corticosteroids" in nonparticipation in early intervention with inhaled corticosteroids in asthma and COPD in general practice.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Screening older patients for obstructive airways disease in a semi-rural practice

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Five-hundred life-saving interventions and their cost-effectiveness

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.11.2003151

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43819597&oldid=2103633280"